1,612
Participants
Start Date
October 27, 2016
Primary Completion Date
June 27, 2018
Study Completion Date
November 26, 2018
HRV PCV-free liquid vaccine
Subjects will receive two doses of PCV-free HRV vaccine at 6 and 12 weeks of age. The vaccine will be administered orally
Rotarix
Subjects will receive two doses of currently licensed lyophilised HRV vaccine at 6 and 12 weeks of age. The vaccine will be administered orally
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Hsinchu
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Taichung
GSK Investigational Site, Taichung
GSK Investigational Site, Castellon
GSK Investigational Site, Castellon
GSK Investigational Site, Erie
GSK Investigational Site, Turku
GSK Investigational Site, Incheon
GSK Investigational Site, Gangwon-do
GSK Investigational Site, Madrid
GSK Investigational Site, Pori
GSK Investigational Site, Málaga
GSK Investigational Site, Antequera/Málaga
GSK Investigational Site, Cheraw
GSK Investigational Site, Marbella
GSK Investigational Site, Tampere
GSK Investigational Site, Birmingham
GSK Investigational Site, Seville
GSK Investigational Site, Cleveland
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Goch
GSK Investigational Site, Bramsche
GSK Investigational Site, Marshfield
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Kansas City
GSK Investigational Site, Topeka
GSK Investigational Site, Kokkola
GSK Investigational Site, Newton
GSK Investigational Site, Frankenthal
GSK Investigational Site, Mannheim
GSK Investigational Site, Schönau am Königssee
GSK Investigational Site, Nampa
GSK Investigational Site, Layton
GSK Investigational Site, Orem
GSK Investigational Site, Syracuse
GSK Investigational Site, Murray
GSK Investigational Site, Provo
GSK Investigational Site, Oulu
GSK Investigational Site, Paramount
GSK Investigational Site, Anaheim
GSK Investigational Site, San Jose
GSK Investigational Site, Sacramento
GSK Investigational Site, Tauberbischofsheim
GSK Investigational Site, Gyeonggido
GSK Investigational Site, North Charleston
GSK Investigational Site, San José
GSK Investigational Site, San José
GSK Investigational Site, Espoo
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Chiba
GSK Investigational Site, Chiba
GSK Investigational Site, Saitama
GSK Investigational Site, Saitama
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY